BOT 16.9% 38.0¢ botanix pharmaceuticals ltd

Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus, page-582

  1. 20 Posts.
    lightbulb Created with Sketch. 11
    https://hotcopper.com.au/data/attachments/2877/2877459-cd8e1559a71988450b54c82354f9f48e.jpg
    I assume you can't read @Timomo.

    Highly likely acne is effective due to antibacterial and not as effective where hormonal drivers are an issue.

    Based on what? Well done you have just worked out the mechanism, if you are not a medical researcher you need to be. The evidence for my statement is all in the well run phase 2 trials, if you take the time to analyse it property.

    You will need to wait for phase 3 results to have a tanty about that but you dont hold so why care?

    I have held, and it is on my watch list. Also the design of the trial will definitely not show up Permetrix, as they will not completely balls up the trial this time and that will only be coupled with the active ingredient.

    I am sorry that you only want sycophant's towards BOT. I look forward to posting again after the cap raising for the phase 111 trials that will dilute you to oblivion. I will pick some up again after that, as I do think the combined Permetrix and their formula will be effective against acne, it is the smoke and mirrors that I object to.
    Last edited by jpz1234: 05/02/21
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
38.0¢
Change
0.055(16.9%)
Mkt cap ! $687.8M
Open High Low Value Volume
33.0¢ 38.0¢ 33.0¢ $7.103M 19.63M

Buyers (Bids)

No. Vol. Price($)
5 134000 37.5¢
 

Sellers (Offers)

Price($) Vol. No.
38.0¢ 650314 19
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.